1. Home
  2. INAB vs GNS Comparison

INAB vs GNS Comparison

Compare INAB & GNS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • INAB
  • GNS
  • Stock Information
  • Founded
  • INAB 2016
  • GNS 2002
  • Country
  • INAB United States
  • GNS Singapore
  • Employees
  • INAB N/A
  • GNS N/A
  • Industry
  • INAB Biotechnology: Pharmaceutical Preparations
  • GNS Other Consumer Services
  • Sector
  • INAB Health Care
  • GNS Real Estate
  • Exchange
  • INAB Nasdaq
  • GNS Nasdaq
  • Market Cap
  • INAB 18.8M
  • GNS 17.8M
  • IPO Year
  • INAB 2021
  • GNS 2022
  • Fundamental
  • Price
  • INAB $0.19
  • GNS $0.35
  • Analyst Decision
  • INAB Strong Buy
  • GNS
  • Analyst Count
  • INAB 2
  • GNS 0
  • Target Price
  • INAB $3.60
  • GNS N/A
  • AVG Volume (30 Days)
  • INAB 786.0K
  • GNS 1.9M
  • Earning Date
  • INAB 05-08-2025
  • GNS 05-14-2025
  • Dividend Yield
  • INAB N/A
  • GNS N/A
  • EPS Growth
  • INAB N/A
  • GNS N/A
  • EPS
  • INAB N/A
  • GNS N/A
  • Revenue
  • INAB N/A
  • GNS $16,147,348.00
  • Revenue This Year
  • INAB N/A
  • GNS N/A
  • Revenue Next Year
  • INAB N/A
  • GNS $47.43
  • P/E Ratio
  • INAB N/A
  • GNS N/A
  • Revenue Growth
  • INAB N/A
  • GNS N/A
  • 52 Week Low
  • INAB $0.13
  • GNS $0.21
  • 52 Week High
  • INAB $1.74
  • GNS $5.69
  • Technical
  • Relative Strength Index (RSI)
  • INAB 49.14
  • GNS 57.76
  • Support Level
  • INAB $0.15
  • GNS $0.26
  • Resistance Level
  • INAB $0.18
  • GNS $0.26
  • Average True Range (ATR)
  • INAB 0.02
  • GNS 0.03
  • MACD
  • INAB 0.01
  • GNS 0.01
  • Stochastic Oscillator
  • INAB 93.22
  • GNS 95.74

About INAB IN8bio Inc.

IN8bio Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of gamma-delta T cell product candidates for solid and liquid tumors, by employing allogeneic, autologous, and genetically modified gamma-delta T cells. Its product candidates include INB-400, for the treatment of newly diagnosed glioblastoma, or GBM, INB-100 for the treatment of patients with high-risk leukemias undergoing hematopoietic stem cell transplantation, and other product candidates such as INB-200, INB-300, and INB-500.

About GNS Genius Group Limited

Genius Group Ltd is an Edtech and education company that provides entrepreneur education system business development tools and management consultancy services to entrepreneurs and entrepreneur resorts. The company's business consists of two reportable business segments: Education - entrepreneur education, management consultancy, and business development tools; and Campus - resorts, retreats, and co-working cafes for entrepreneurs. It derives the majority of its revenue from the Education segment.

Share on Social Networks: